￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Bimetinib for the treatment of melanoma: Should the drug be discontinued if the rash is severe?

2026-02-01 22:25:32

Check Details
Teritusumab subcutaneous administration: is the efficacy better than intravenous injection?

2026-02-01 22:25:32

Check Details
Quizartinib for treating AML in children: What are the safety data?

2026-02-01 22:25:32

Check Details
Is pomalidomide a chemotherapy drug or a targeted drug?

2026-02-01 22:25:32

Check Details
Lapatinib in the treatment of male breast cancer: whether there are differences in efficacy

2026-02-01 22:25:32

Check Details
What is the main therapeutic effect of filgotinib?

2026-02-01 22:25:32

Check Details
Study on the association between bosutinib/bosutinib and Src kinase inhibition

2026-02-01 22:25:32

Check Details
Research and effects of milizumab dose optimization protocol

2026-02-01 22:25:32

Check Details
Introduction to the characteristics and drug information of the US version of cabozantinib

2026-02-01 22:25:32

Check Details
Is there a generic drug market for lorlatinib/lorlatinib?

2026-02-01 22:25:32

Check Details
Upatinib medical insurance coverage: new indications in 2025

2026-02-01 22:25:32

Check Details
Nintedanib in SSc-ILD: Can skin sclerosis be reversed?

2026-02-01 22:25:32

Check Details
Category
相关知识